Skip to content

Medical-device intelligence

CGI: Radioimmunoassay, Estriol

FDA product code CGI: Radioimmunoassay, Estriol. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
CGI
FDA device name
Radioimmunoassay, Estriol
Device class
1
Regulation number
862.1265
Medical specialty
Clinical Chemistry
Review panel
CH

The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.

Explore clinical chemistry records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

42 clearance records and 2 recall records in the covered releases, across 28 source company names and 1 product codes. Dated history runs from Jun 2, 1977 to Aug 26, 2020.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
CGI · Radioimmunoassay, Estriol422

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

44 matching records
Device / recordCompany in FDA recordSourceSource date
NATAL-TEC ESTRIOLK811371 · CGIArmkel, LLC510(k)May 29, 1981FDA decision date
AMERLEX ESTRIOL RIA KITK810667 · CGIAmersham Corp.510(k)Mar 31, 1981FDA decision date
IMMUNOREACTIVE ESTRIOL RIA KITK802754 · CGIMicroanalytic Research, Inc.510(k)Jan 21, 1981FDA decision date
QUANTIMUNE E3 RIAK802944 · CGIBio-Rad510(k)Dec 22, 1980FDA decision date
ESTRIOL-SQUIBB RIA KITK802455 · CGIE. R. Squibb & Sons, Inc.510(k)Oct 31, 1980FDA decision date
ARIA II 125- I-ESTRIOL SYSTEMK801735 · CGIBd Becton Dickinson Vacutainer Systems Preanalytic510(k)Sep 16, 1980FDA decision date
ESTRIOL RIA KIT FOR USE WITH GAMMAFLOK801424 · CGISquibb & Sons, Inc.510(k)Jul 21, 1980FDA decision date
TOTAL ESTRIOL RIA KITK800036 · CGIAmersham Corp.510(k)Jan 21, 1980FDA decision date
NORDICLAB TOTAL ESTRIOL RIA TESTK792189 · CGINordiclab Intl.510(k)Nov 13, 1979FDA decision date
RSL'S ASSAY PROCEDURE QUANTITATIONK791728 · CGIRadioassay Systems Laboratories, Inc.510(k)Sep 27, 1979FDA decision date
I ESTRIOLK790008 · CGICambridge Nuclear Corp.510(k)Feb 26, 1979FDA decision date
RIA KIT, GAMMADAB ESTRIOLK781938 · CGIClinical Assays, Inc.510(k)Jan 10, 1979FDA decision date
RIA, QUANTIMUNE E3K781850 · CGIBio-Rad510(k)Jan 3, 1979FDA decision date
DIRECT ESTRIOL RIA KITK781546 · CGIImmunalysis Corporation510(k)Dec 4, 1978FDA decision date
I-ESTRIOL TEST SETK781599 · CGIWien Laboratories, Inc.510(k)Oct 17, 1978FDA decision date
HUMAN FOLLICLE STIMULATING HORMONEK780016 · CGIPcl-Ria, Inc.510(k)Feb 3, 1978FDA decision date
RIANEN ESTRIOL RIA KITK772323 · CGINew England Nuclear510(k)Jan 5, 1978FDA decision date
UNCONJUGATED ESTRIOL RIA KITK772215 · CGIAmersham Corp.510(k)Dec 22, 1977FDA decision date
RIA-120 AND ESTRIOL REAGENT SYSTEMK770465 · CGIBd Becton Dickinson Vacutainer Systems Preanalytic510(k)Jun 2, 1977FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗